Vice Provost and Dean of Research
Showing 51-100 of 1,742 Results
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
-
Christopher Wallace Austelle
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioChristopher Wallace Austelle, MD, is a board-certified psychiatrist and Clinical Assistant Professor investigating circuit-based treatments for mood and anxiety disorders. As a physician-scientist, he examines how neural circuits involved in emotion and cognition interact with autonomic systems that regulate arousal and internal bodily states, and how disruptions in these integrated systems contribute to depression and anxiety.
With more than a decade of experience in neuromodulation, Dr. Austelle has worked across research and clinical settings using transcranial magnetic stimulation (TMS), accelerated protocols such as Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), transcutaneous auricular vagus nerve stimulation (taVNS), and implanted vagus nerve stimulation (VNS). His research integrates clinical trials, neuroimaging, and psychophysiology to develop targeted, physiology-informed interventions.
Clinically, he specializes in treatment-resistant depression and anxiety disorders, applying evidence-based neuromodulation strategies for individuals who have not responded to standard treatments. -
Jeffrey Axelrod
Professor of Pathology
Current Research and Scholarly InterestsGenetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.
-
Dan E. Azagury, MD, FACS
Associate Professor of Surgery (General Surgery)
Current Research and Scholarly Interests.
-
Rosa Bacchetta
Professor (Research) of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.
Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.
For further information please visit the Bacchetta Lab website:
http://med.stanford.edu/bacchettalab.html -
Stephen A. Baccus
Professor of Neurobiology
Current Research and Scholarly InterestsWe study how the neural circuitry of the vertebrate retina encodes visual information and performs computations. To control and measure the retinal circuit, we present visual images while performing simultaneous two-photon imaging and multielectrode recording. We perturb the circuit as it operates using simultaneous intracellular current injection and multielectrode recording, and use the resulting large data sets to construct models of retinal computation.
-
Amir Bahmani
Instructor, Genetics
BioAmir Bahmani is a Genetics Instructor and Director of Stanford's Deep Data Research Center (https://deepdata.stanford.edu ) at the Stanford School of Medicine. He has worked on distributed and parallel computing applications since 2008. Amir is currently an active researcher in the VA Million Veteran Program (MVP), Human Tumor Atlas Network (HTAN), Human BioMolecular Atlas Program (HuBMAP), Stanford Metabolic Health Center (MHC), Integrated Personal Omics Profiling (iPOP), and Bridge to Artificial Intelligence (Bridge2AI).
His team has designed and developed several notable cloud-scale frameworks, including the Personal Health Dashboard (PHD), cloud-based cost-saving platforms such as Hummingbird and Swarm, and the MyPHD platform, which now has over 12,000 participants and hosts more than 37 studies. His team also created Stanford Data Ocean (SDO), an innovative platform for educating engineers and biologists. SDO is the first serverless multi-omics and wearables data platform used for education and training.
Since 2017, he has trained more than 30 graduate interns (engineers and designers) from outside the School of Medicine, engaging them in the field of medicine. His course has been offered to physicians, biologists, engineers, and designers, earning him recognition as the recipient of Stanford’s 2024 Walter J. Gores Award for Excellence in Teaching. In 2023, he received the Terman Mentorship Award for mentoring Terman Fellow Ryan Park (top 1%), who transitioned to a Genetics PhD program inspired by Amir’s course. Committed to accessibility in education, Amir created a first-of-its-kind scholarship for under-resourced communities at Stanford, providing his course free of charge—along with Genetics certificates—to over 4,500 students from under-resourced backgrounds across 104 countries and all 50 U.S. states. -
Fred M Baik, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Baik is Assistant Professor of Otolaryngology – Head & Neck Surgery at Stanford University. He provides comprehensive surgical care for patients with head and neck cancer, both as an ablative and reconstructive surgeon. His clinical interests include oral cavity cancer, complex skin cancer, microvascular reconstruction and the diagnosis and management of nodal metastasis. With his background in fluorescence imaging, Dr. Baik’s research focuses on surgical navigation using targeted agents to improve tumor margin assessment and the detection of nodal metastasis, and he currently leads several clinical trials to translate novel imaging techniques.
Dr. Baik graduated with honors in Biology at the University of Pennsylvania and received his medical degree at UC San Diego. After completing his Otolaryngology residency at the University of Washington, he pursued advanced training in Head and Neck Oncology & Reconstructive Surgery at Mount Sinai Beth Israel Hospital in New York City. He is a board-certified by the American Board of Otolaryngology, and a member of the American Head and Neck Society, American Academy of Otolaryngology – Head and Neck Surgery, and a fellow of the American College of Surgeons. -
Jeremy Bailenson
Thomas More Storke Professor, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Education
BioJeremy Bailenson is founding director of Stanford University’s Virtual Human Interaction Lab, Thomas More Storke Professor in the Department of Communication, Professor (by courtesy) of Education, Professor (by courtesy) Program in Symbolic Systems, and a Senior Fellow at the Woods Institute for the Environment. He has served as Director of Graduate Studies in the Department of Communication for fifteen years. He earned a B.A. from the University of Michigan in 1994 and a Ph.D. in cognitive psychology from Northwestern University in 1999. He spent four years at the University of California, Santa Barbara as a Post-Doctoral Fellow and then an Assistant Research Professor.
Bailenson studies the psychology of Virtual and Augmented Reality, in particular how virtual experiences lead to changes in perceptions of self and others. His lab builds and studies systems that allow people to meet in virtual space, and explores the changes in the nature of social interaction. His most recent research focuses on how virtual experiences can transform education, environmental conservation, empathy, and health. He is the recipient of the Dean’s Award for Distinguished Teaching at Stanford. In 2020, IEEE recognized his work with “The Virtual/Augmented Reality Technical Achievement Award”.
He has published more than 250 academic papers, spanning the fields of communication, computer science, education, environmental science, law, linguistics, marketing, medicine, political science, and psychology. His work has been continuously funded by the National Science Foundation for over 25 years.
His first book Infinite Reality, co-authored with Jim Blascovich, emerged as an Amazon Best-seller eight years after its initial publication, and was quoted by the U.S. Supreme Court. His new book, Experience on Demand, was reviewed by The New York Times, The Wall Street Journal, The Washington Post, Nature, and The Times of London, and was an Amazon Best-seller.
He has written opinion pieces for The Washington Post, The Wall Street Journal, Harvard Business Review, CNN, PBS NewsHour, Wired, National Geographic, Slate, The San Francisco Chronicle, TechCrunch, and The Chronicle of Higher Education, and has produced or directed six Virtual Reality documentary experiences which were official selections at the Tribeca Film Festival. His lab has exhibited VR in hundreds of venues ranging from The Smithsonian to The Superbowl. -
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
On Partial Leave from 01/01/2026 To 12/01/2026BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Julie Baker
Professor of Genetics
Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.
-
Laurence Baker
Professor of Health Policy, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics
Current Research and Scholarly InterestsDr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
-
Karthik Balakrishnan, MD, MPH, FAAP, FACS
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Balakrishnan's research focuses on innovative ways to improve and standardize treatments and measure outcomes in complex pediatric airway and aerodigestive conditions , as well as ways to reduce treatment costs and medical errors. By improving outcomes and reducing costs, he aims to improve the value of care, while also optimizing patient and caregiver experience during the care process.
-
Halleh Balch
Assistant Professor of Oceans and, by courtesy, of Electrical Engineering
BioHalleh B. Balch is an experimental physicist and HHMI Hanna H. Gray Faculty Fellow at Stanford University. Her research broadly focuses on advancing imaging, spectroscopy, and nanophotonics with a focus on applications in oceanography and water sustainability. Halleh received her PhD in physics from the University of California Berkeley and her undergraduate degree from Swarthmore College in physics and literature. Halleh joined Stanford as an Assistant Professor in the Doerr School of Sustainability in August 2025.
-
Nicholas Bambos
Richard W. Weiland Professor in the School of Engineering and Professor of Electrical Engineering
BioNick Bambos is R. Weiland Professor in the School of Engineering at Stanford University, having a joint appointment in the Department of Electrical Engineering and the Department of Management Science & Engineering. He has been the Fortinet Founders Department Chair of the Management Science & Engineering Department (2016 – 20).
He heads the Computer Systems Performance Engineering Lab (Perf-Lab) at Stanford, comprised of doctoral students and industry visitors engaged in various research projects, and was the Director (1999 – 2005) of the Stanford Networking Research Center (a research project of about $30M). He has published over 300 peer-reviewed research publications and graduated over 40 doctoral students (including two post-doctoral ones), who have moved on to leadership positions in academia, the Silicon Valley industries and technology startups, finance and venture capital, etc.
His research interests are in architecture and high-performance engineering of computer systems and networks, as well as data analytics with an emphasis on medical and health-care analytics. His research contributions span the areas of networking and the Internet, cloud computing and data centers, multimedia streaming, computer security, digital health, etc. His methodological interests and contributions span the areas of network control, online task scheduling, routing and distributed processing, machine learning and artificial intelligence, etc.
He received his Ph.D. (1989) in Electrical Engineering & Computer Sciences from the University of California at Berkeley. Before joining Stanford in 1996, he served as assistant professor (1989 – 95) and tenured associate professor (1995 – 96) of Electrical Engineering at the University of California at Los Angeles (UCLA).
He has received several best research paper awards and has been the Cisco Systems Faculty Development Chair and the David Morgenthaler Faculty Scholar at Stanford. He has won the IBM Faculty Award, as well as the National Young Investigator Award and the Research Initiation Award from the National Science Foundation. He has been a Berkeley U.C. Regents Fellow, an E. C. Anthony Fellow, and a D. & S. Gale Fellow.
He has served on various editorial boards of research journals, scientific boards of research labs, international technical and scientific committees, and technical review panels for networking and computing technologies. He has also served on corporate technical boards, as consultant and co-founder of technology start-up companies, and as expert witness in high-profile patent litigation and other legal cases involving information technologies. -
Niaz Banaei
Professor of Pathology and of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Steven Banik
Assistant Professor of Chemistry
BioSteven Banik’s research interests center on rewiring mammalian biology and chemical biotechnology development using molecular design and construction. Projects in the Banik lab combine chemical biology, organic chemistry, protein engineering, cell and molecular biology to precisely manipulate the biological machines present in mammalian cells. Projects broadly aim to perform new functions that shed light on regulatory machinery and the potential scope of mammalian biology. A particular focus is the study of biological mechanisms that can be coopted by synthetic molecules (both small molecules and proteins). These concepts are applied to develop new therapeutic strategies for treating aging-related disorders, genetic diseases, and cancer.
Prior to joining the faculty at Stanford, Steven was a NIH and Burroughs CASI postdoctoral fellow advised by Prof. Carolyn Bertozzi at Stanford. His postdoctoral research developed approaches for targeted protein degradation from the extracellular space with lysosome targeting chimeras (LYTACs). He received his Ph.D. from Harvard University in 2016, where he worked with Prof. Eric Jacobsen on synthetic methods for the selective, catalytic difluorination of organic molecules and new approaches for generating and controlling reactive cationic intermediates in asymmetric catalysis. -
Matei Banu, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Matei Banu is a fellowship-trained neurosurgeon at Stanford Health Care. He is also a clinical assistant professor in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Banu specializes in treating brain, skull base, and pituitary tumors. He also specializes in the management of the buildup of brain fluid (hydrocephalus) and related conditions. He is skilled in minimally invasive techniques, such as microscopic surgery (using microscopes and tiny instruments to repair small structures) and endoscopic techniques (using a thin, flexible tube to take pictures inside the body).
Dr. Banu often collaborates with rhinologists (doctors who diagnose and treat diseases of the nose and sinuses), head and neck surgeons, and otologists (doctors who diagnose and treat ear-related conditions). His goals are ensuring each patient receives comprehensive care and providing precise, compassionate treatment that enhances each patient’s quality of life.
His research interests include developing personalized treatment strategies for brain and skull base cancers. Dr. Banu is exploring how aggressive tumors grow, resist treatment, and evade the immune system. Using tumor samples from patients, Dr. Banu and his team are testing novel drugs to create more effective therapies.
Dr. Banu has published his research in several peer-reviewed journals, including Lancet Oncology, Cell, Nature Cell Biology, and Nature Communications. He has also contributed book chapters on topics like pediatric endoscopic skull base surgery and drug delivery for brain tumors. He has shared his findings at numerous national and international meetings in neurosurgery and oncology.
Dr. Banu is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the North American Skull Base Society, and the Society for Neuro-Oncology. -
Zhenan Bao
K. K. Lee Professor, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering, of Chemistry, and of Bioengineering
BioZhenan Bao joined Stanford University in 2004. She is currently a K.K. Lee Professor in Chemical Engineering, and with courtesy appointments in Chemistry, Bioengineering and Material Science and Engineering. She was the Department Chair of Chemical Engineering from 2018-2022 and in 2025. She founded the Stanford Wearable Electronics Initiative (eWEAR) and is the current faculty director. Bao received her Ph.D. degree in Chemistry from The University of Chicago in 1995 and joined Bell Labs, Lucent Technologies. She became a Distinguished Member of Technical Staff in 2001. Professor Bao currently has more than 800 refereed publications and more than 80 US patents with a Google Scholar H-index 237.
Bao is a member of the US National Academy of Sciences, National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. Bao was elected a foreign member of the Chinese Academy of Science in 2021. She is a Fellow of AAAS, ACS, MRS, SPIE, ACS POLY and ACS PMSE.
Bao is a member of the Board of Directors for the Camille and Dreyfus Foundation from 2022. She served as a member of Executive Board of Directors for the Materials Research Society and Executive Committee Member for the Polymer Materials Science and Engineering division of the American Chemical Society. She co-founded C3 Nano Co. (acquired by Du Pont) and PyrAmes, which have produced products used in commercial smartphones and hospitals, respectively. Multiple inventions from her lab have been licensed and served as foundational technologies for several additional start-ups.
Bao was a recipient of the VinFuture Prize Female Innovator 2022, ACS Award of Chemistry of Materials 2022, MRS Mid-Career Award in 2021, AICHE Alpha Chi Sigma Award 2021, ACS Central Science Disruptor and Innovator Prize in 2020, ACS Gibbs Medal in 2020, the Wilhelm Exner Medal from the Austrian Federal Minister of Science in 2018, the L'Oreal UNESCO Women in Science Award North America Laureate in 2017. She was awarded the ACS Applied Polymer Science Award in 2017, ACS Creative Polymer Chemistry Award in 2013 ACS Cope Scholar Award in 2011. She is a recipient of the Royal Society of Chemistry Beilby Medal and Prize in 2009, IUPAC Creativity in Applied Polymer Science Prize in 2008.
In Stanford, Bao has pioneered molecular design concepts and fabrication processes to advance the scope and applications of skin-inspired electronics. Her group discovered nano confinement effect of conjugated polymers in polymer blends, which established the fundamental foundation for skin-inspired electronic materials and devices. Her work has resulted in new materials and device solutions for soft robotics, wearable and implantable electronics for precision health, precision mental health and advanced tools for understanding neuroscience and treatment of neurodegenerative diseases. Building on chemical insights, her group has developed foundational materials and devices that enabled a new generation of skin-inspired soft electronics. They provide unprecedented opportunities for understanding human health through developing monitoring, diagnosis and treatment tools. Some examples include: a neuromorphic e-skin that can sense force and temperature and directly communicate with brain, a wireless wound healing patch, a soft NeuroString for simultaneous neurochemical monitoring in the brain and gut, soft high-density electrophysiological recording array, a meta-learned skin sensor for detailed body movements, a reconfigurable self-healing electronic skin. -
Maria Barna
Associate Professor of Genetics
Current Research and Scholarly InterestsOur lab studies how intricate control of gene expression and cell signaling is regulated on a minute-by-minute basis to give rise to the remarkable diversity of cell types and tissue morphology that form the living blueprints of developing organisms. Work in the Barna lab is presently split into two main research efforts. The first is investigating ribosome-mediated control of gene expression genome-wide in space and time during cellular differentiation and organismal development. This research is opening a new field of study in which we apply sophisticated mass spectrometry, computational biology, genomics, and developmental genetics, to characterize a ribosome code to gene expression. Our research has shown that not all of the millions of ribosomes within a cell are the same and that ribosome heterogeneity can diversify how genomes are translated into proteomes. In particular, we seek to address whether fundamental aspects of gene regulation are controlled by ribosomes harboring a unique activity or composition that are tuned to translating specific transcripts by virtue of RNA regulatory elements embedded within their 5’UTRs. The second research effort is centered on employing state-of-the-art live cell imaging to visualize cell signaling and cellular control of organogenesis. This research has led to the realization of a novel means of cell-cell communication dependent on a dense network of actin-based cellular extension within developing organs that interconnect and facilitate the precise transmission of molecular information between cells. We apply and create bioengineering tools to manipulate such cellular interactions and signaling in-vivo.
-
Christopher O. Barnes
Assistant Professor of Biology and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsResearch in our lab is aimed at defining the structural correlates of broad and potent antibody-mediated neutralization of viruses. We combine biophysical and structural methods (e.g., cryo-EM), protein engineering, and in vivo approaches to understand how enveloped viruses infect host cells and elicit antigen-specific immune responses. We are particularly interested in the co-evolution of HIV-1 and broadly-neutralizing IgG antibodies (bNAbs), which may hold the key to the development of an effective HIV-1 vaccine. In addition, we are investigating antibody responses to SARS-CoV-2 and related zoonotic coronaviruses (CoV), with the related goal of developing broadly-protective immunotherapies and vaccines against variants of concern and emerging CoV threats.
HIV-1; SARS-CoV-2; coronaviruses; cryo-EM; crystallography; vaccines; directed evolution -
Dalya Baron
Physical Sci Res Scientist
Current Research and Scholarly InterestsI am interested in galaxy evolution, supermassive black holes and their impact on their host galaxies, and the physics of the interstellar medium. I am an observer, and obtain multi-wavelength observations using different facilities and instruments. I also analyze large astronomical surveys, and use machine learning and data science techniques to mine them for novel information.
-
Annelise E. Barron
Associate Professor of Bioengineering
Current Research and Scholarly InterestsBiophysical mechanisms of host defense peptides (a.k.a. antimicrobial peptides) and their peptoid mimics; also, molecular and cellular biophysics of human innate immune responses.
-
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine, Senior Fellow at the Woods Institute and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsAreas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Human and Planetary Heath
Women Leadership -
Greg Barsh
Professor of Genetics and of Pediatrics, Emeritus
Current Research and Scholarly InterestsGenetics of color variation
-
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
-
Glaivy Batsuli, MD
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.
Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease. -
Fiona Baumer
Assistant Professor of Neurology (Pediatric Neurology)
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Mohsen Bayati
Carl and Marilynn Thoma Professor in the Graduate School of Business and Professor, by courtesy, of Electrical Engineering and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly Interests1) Healthcare management: I am interested in improving healthcare delivery using data-driven modeling and decision-making.
2) Network models and message-passing algorithms: I work on graphical modeling ideas motivated from statistical physics and their applications in statistical inference.
3) Personalized decision-making: I work on machine learning and statistical challenges of personalized decision-making. The problems that I have worked on are primarily motivated by healthcare applications. -
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner, MD, MPH is an Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Cardiac Electrophysiology at Stanford University School of Medicine. She completed residency and fellowships in cardiovascular medicine and advanced heart failure at the University of California, San Diego, followed by fellowship training in cardiac electrophysiology at Stanford. She joined the Stanford faculty in 2018 and was promoted to Assistant Professor in 2023.
Dr. Baykaner’s research program focuses on atrial fibrillation (AF), cardio-oncology, and the integration of artificial intelligence and machine learning into cardiac electrophysiology. She is Principal Investigator of an NIH R01 investigating atrial fibrillation in patients with hematologic malignancies treated with tyrosine kinase inhibitors and previously led an NIH K23 award focused on personalizing AF management using machine learning. She also serves as co-investigator or consultant on multiple NIH-funded R01 projects in artificial intelligence, ventricular arrhythmias, and digital cardiovascular phenotyping. Her work spans AF mechanisms, ablation outcomes, digital health implementation, and equity in arrhythmia care.
She has authored over 200 peer-reviewed publications, book chapters, and abstracts, including more than 100 original research manuscripts, and has delivered over 100 invited lectures nationally and internationally. She served as a task force member for the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation and holds editorial leadership roles, including Associate Editor for the Journal of Interventional Cardiac Electrophysiology and editorial board positions with multiple electrophysiology journals.
Dr. Baykaner is Vice-Chair of the Heart Rhythm Society Digital Education Committee and serves on national program and grant review committees, including NIH/NHLBI study sections. She is actively engaged in mentorship across undergraduate, medical, graduate, and postdoctoral levels, with mentees who have received national awards and progressed to electrophysiology fellowship and faculty positions.
Her clinical practice focuses on catheter ablation of atrial and ventricular arrhythmias, supraventricular tachycardias, management of inappropriate sinus tachycardia, cardiac implantable electronic device implantation and extraction, and advanced rhythm management strategies in complex patient populations. -
Philip Beachy
The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.
-
Christopher Beaulieu M.D., Ph.D.
Professor of Radiology (Musculoskeletal Imaging)
On Partial Leave from 01/05/2026 To 06/26/2026Current Research and Scholarly InterestsInformatics and image processing techniques that provide infrastructure for diagnosis in musculoskeletal imaging. Decision support for improving accuracy of bone tumor diagnosis. Improved methods for MRI in the musculoskeletal system.
-
Barry Behr, Ph.D., H.C.L.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility), Emeritus
Current Research and Scholarly InterestsDevelopment of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.
-
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Gill Bejerano
Professor of Developmental Biology, of Computer Science and of Pediatrics (Genetics)
Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system.
